+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orthopedic Consumables - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 119 Pages
  • October 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6292864
The orthopedic consumables market size is projected to be USD 9 billion in 2025, USD 9.29 billion in 2026, and reach USD 10.94 billion by 2031, growing at a CAGR of 3.31% from 2026 to 2031. This report is Segmented by Product Type (Surgical, Wound-Management, Casting/Splinting, Arthroscopy, and Other), Application (Trauma, Joint Replacement, Spine, and More), End User (Hospitals, Ascs, Homecare, Other), Distribution Channel (Direct, Distributor/GPO, Retail, and E-Commerce), & Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). Forecasts are in Value (USD).

Global Orthopedic Consumables Market Trends and Insights

Aging Population and Rising Osteoarthritis Burden

Osteoarthritis creates sustained demand for the orthopedic consumables market because treatment needs are concentrated in older patient groups with high procedure use. A 2025 analysis in Arthritis Research & Therapy reported that 607 million people lived with osteoarthritis globally in 2021, compared with 256 million in 1990. The study also reported a 9.2% increase in age-standardized prevalence during that period and projected a further 14% increase by 2050. Knee osteoarthritis represented more than 56% of the global burden, while high body mass index accounted for 21% of osteoarthritis-related disability-adjusted life years. These patterns support demand for products used in joint reconstruction, trauma care, wound management, and postoperative recovery. The burden is particularly significant in high-income health systems, where access to surgery and spending per procedure are higher.

Increasing Orthopedic Procedure Volumes from Trauma and Sports Injuries

Trauma surgery held 42.54% of the orthopedic consumables market in 2025, reflecting the steady need for products used in fracture treatment and urgent surgery. Road accidents, falls, fragility fractures, and high-energy sports injuries sustain procedure demand across age groups. Sports medicine and soft-tissue repair are forecast to grow at a 5.76% CAGR through 2031 as surgical options broaden for active patients. The use of bioabsorbable fixation devices and biologic materials is extending from elective sports procedures into some trauma care pathways. This expands the role of specialized consumables in the largest application area without changing the importance of high-volume trauma supplies. Suppliers with products that fit both trauma and sports medicine workflows can address a broader clinical base.

High Cost of Advanced Orthopedic Consumables and Procedures

High prices can limit adoption in the orthopedic consumables market when reimbursement does not cover the full cost of advanced procedure bundles. The constraint is most pronounced in health systems outside North America and Western Europe, where spending limits affect the use of biologic kits, specialized draping systems, and advanced wound materials. Volume-based purchasing can expand procedure access while placing pressure on the value captured by suppliers. This environment requires companies to support premium prices with evidence on complications, length of stay, and readmissions. Hospital formulary decisions increasingly depend on whether clinical advantages can be linked to economic value. Companies without this evidence risk being excluded when purchasing committees standardize product choices.

Other drivers and restraints analyzed in the report include:
  • Shift Toward Minimally Invasive and Ambulatory Orthopedic Procedures
  • Expansion of Orthopedic Surgical Capacity in Asia-Pacific and Emerging Markets
  • Procurement Pressure from Volume-Based Tenders and Hospital Consolidation

Segment Analysis

Surgical orthopedic consumables held 48.65% of the orthopedic consumables market share in 2025, supported by frequent use in trauma and joint replacement procedures. This group includes disposable drapes, bone cement mixing systems, lavage devices, and sterile instrument kits. The leading position reflects the recurring need for these materials in each procedure rather than one-time capital equipment spending. Casting and splinting consumables serve high-volume trauma and sports injury pathways, although pricing is competitive. Synthetic casting materials are gradually replacing plaster of Paris in developed health systems. Arthroscopy consumables are also moving toward products that support robotic and navigation-assisted procedures in the orthopedic consumables market.

Wound-management orthopedic consumables are forecast to grow at a 5.54% CAGR through 2031. The expansion reflects the movement of recovery and wound treatment into outpatient and homecare settings. These settings need products that can be handled outside an acute-care hospital and purchased in smaller volumes. Other orthopedic consumables include bioabsorbable implants and intraoperative diagnostic materials, where several specialized categories are grouped together. The orthopedic consumables industry is therefore seeing demand for both established surgical supplies and more specialized products used after discharge.

Trauma surgery accounted for 42.54% of category revenue in 2025, making it the largest application segment. Its position is supported by the continuing need to treat road injuries, fall-related fractures, and other acute conditions. The supplied source material reported global trauma implant sales of USD 9.6 billion in 2025, with 5.8% year-over-year growth. Joint Replacement and Spine Surgery also creates material demand because procedures use multiple sterile and procedure-specific items. Spine care can require higher consumable use when navigation systems and expandable cage technologies are used. Wound Management and Postoperative Care remain important as payers encourage earlier discharge from acute settings in the orthopedic consumables market.

Sports medicine and soft-tissue repair are forecast to expand at a 5.76% CAGR through 2031. Arthrex released the TightRope SB All-Suture Implant in February 2026 for anterior cruciate ligament reconstruction. The supplied material described it as the first all-suture soft-button technology in an anterior cruciate ligament fixation device. New fixation and biologic options raise the clinical requirements for sports procedures and may increase the use of specialized materials. The orthopedic consumables industry is also linking sports medicine products more closely with the needs of patients receiving minimally invasive care. This makes the segment important for suppliers seeking growth beyond the large trauma base.

Complete Report Scope:

  • By Product Type
    • Surgical Orthopedic Consumables
    • Wound-Management Orthopedic Consumables
    • Casting and Splinting Consumables
    • Arthroscopy Consumables
    • Other Orthopedic Consumables
  • By Application
    • Trauma Surgery
    • Joint Replacement
    • Spine Surgery
    • Sports Medicine and Soft-Tissue Repair
    • Wound Management and Postoperative Care
    • Other Applications
  • By Distribution Channel
    • Direct Sales
    • Distributor and Group Purchasing Organization Sales
    • Retail Pharmacies and Medical Supply Stores
    • E-Commerce Platforms
  • By End User
    • Hospitals and Surgical Centers
    • Ambulatory Surgical Centers
    • Homecare Settings
    • Other End Users
  • Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Geography Analysis

North America accounted for 41.54% of the orthopedic consumables market share in 2025. The region benefits from high procedure volumes, established reimbursement, and demand for products used in complex elective and trauma cases. The 2026 expansion of the ambulatory surgery center covered procedures list adds 168 orthopedic codes in the United States. This broadens the number of care settings that can purchase orthopedic products. Suppliers that were previously dependent on hospital group purchasing channels can address a more varied institutional base. Canada and Mexico provide additional regional demand, including some cross-border care flows near the U.S.-Mexico border.

Europe has a split between high-volume, well-reimbursed countries and more price-sensitive systems in the orthopedic consumables market. Germany held the largest national share of the European orthopedic devices market in 2025 at 23.15%, according to the supplied Mordor Intelligence material. Strong statutory insurance coverage, a high surgeon base, and domestic manufacturing support its role in regional demand. The European Union Medical Device Regulation continues to affect product decisions by raising conformity assessment requirements for reusable Class I devices. Some manufacturers face a choice between recertifying reusable lines and focusing more on disposable alternatives. The United Kingdom is forecast to record a 5.92% CAGR through 2031 as elective surgery activity recovers.

Asia-Pacific is forecast to grow at a 4.53% CAGR through 2031, the fastest pace among the listed regions. The orthopedic consumables market size in the region is supported by healthcare capacity expansion in China and India, where demand is growing with aging urban populations. Johnson & Johnson’s DePuy Synthes established a Global Capability Center in Bangalore in 2026 and planned a 500-person technical team, according to the supplied material. Apollo Hospitals completed more than 2,000 robotic-assisted orthopedic surgeries in September 2026. The Middle East and Africa demand is supported by the Gulf Cooperation Council's infrastructure spending and medical tourism. In South America, demand is concentrated in Brazil and Argentina, where public budgets and imported product dependence create both opportunity and entry barriers.


List of Companies Covered in this Report:

  • ATEC, Inc.
  • Anika Therapeutics
  • Arthrex
  • B. Braun
  • BONESUPPORT AB
  • Conmed
  • DJO Global
  • Enovis Corporation
  • Exactech
  • Globus Medical
  • Integra LifeSciences
  • Johnson & Johnson MedTech
  • Limacorporate S.p.A.
  • Medartis Holding AG
  • Medtronic
  • MicroPort
  • Orthofix
  • OrthoPediatrics Corp.
  • Paragon 28, Inc.
  • SI-BONE, Inc.
  • Smith+Nephew plc
  • Stryker
  • Zimmer Biomet

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope Of The Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging Population and Rising Osteoarthritis Burden
4.2.2 Increasing Orthopedic Procedure Volumes From Trauma and Sports Injuries
4.2.3 Shift Toward Minimally Invasive and Ambulatory Orthopedic Procedures
4.2.4 Expansion of Orthopedic Surgical Capacity in Asia-Pacific and Emerging Markets
4.2.5 Single-Use Conversion for Infection Prevention and Procedure Standardization
4.2.6 Procedure-Specific Biologics and Smart Consumables Enabling Premiumization
4.3 Market Restraints
4.3.1 High Cost of Advanced Orthopedic Consumables and Procedures
4.3.2 Stringent Regulatory Approval and Compliance Requirements
4.3.3 Procurement Pressure From Volume-Based Tenders and Hospital Consolidation
4.3.4 Limited Product Interoperability Across Robotic and Digital Surgical Ecosystems
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat Of New Entrants
4.7.2 Bargaining Power Of Buyers
4.7.3 Bargaining Power Of Suppliers
4.7.4 Threat Of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product Type
5.1.1 Surgical Orthopedic Consumables
5.1.2 Wound-Management Orthopedic Consumables
5.1.3 Casting and Splinting Consumables
5.1.4 Arthroscopy Consumables
5.1.5 Other Orthopedic Consumables
5.2 By Application
5.2.1 Trauma Surgery
5.2.2 Joint Replacement
5.2.3 Spine Surgery
5.2.4 Sports Medicine and Soft-Tissue Repair
5.2.5 Wound Management and Postoperative Care
5.2.6 Other Applications
5.3 By Distribution Channel
5.3.1 Direct Sales
5.3.2 Distributor and Group Purchasing Organization Sales
5.3.3 Retail Pharmacies and Medical Supply Stores
5.3.4 E-Commerce Platforms
5.4 By End User
5.4.1 Hospitals and Surgical Centers
5.4.2 Ambulatory Surgical Centers
5.4.3 Homecare Settings
5.4.4 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(Includes Global Level Overview, Market Level Overview, Core Segments, Financials As Available, Strategic Information, Market Rank/Share For Key Companies, Products & Services, And Recent Developments)}
6.3.1 ATEC, Inc.
6.3.2 Anika Therapeutics, Inc.
6.3.3 Arthrex, Inc.
6.3.4 B. Braun Melsungen AG
6.3.5 BONESUPPORT AB
6.3.6 CONMED Corporation
6.3.7 DJO, LLC
6.3.8 Enovis Corporation
6.3.9 Exactech, Inc.
6.3.10 Globus Medical, Inc.
6.3.11 Integra LifeSciences Holdings Corporation
6.3.12 Johnson & Johnson MedTech
6.3.13 Limacorporate S.p.A.
6.3.14 Medartis Holding AG
6.3.15 Medtronic plc
6.3.16 MicroPort Scientific Corporation
6.3.17 Orthofix Medical Inc.
6.3.18 OrthoPediatrics Corp.
6.3.19 Paragon 28, Inc.
6.3.20 SI-BONE, Inc.
6.3.21 Smith+Nephew plc
6.3.22 Stryker Corporation
6.3.23 Zimmer Biomet Holdings, Inc.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ATEC, Inc.
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BONESUPPORT AB
  • CONMED Corporation
  • DJO, LLC
  • Enovis Corporation
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson MedTech
  • Limacorporate S.p.A.
  • Medartis Holding AG
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Orthofix Medical Inc.
  • OrthoPediatrics Corp.
  • Paragon 28, Inc.
  • SI-BONE, Inc.
  • Smith+Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.